Kumar G. Janoria
About
In The Last Decade
Kumar G. Janoria
12 papers receiving 744 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Molecular Biology 260
- Pharmaceutical Science 224
- Biomaterials 222
- Biomedical Engineering 139
- Ophthalmology 137
Countries citing papers authored by Kumar G. Janoria
This map shows the geographic impact of Kumar G. Janoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar G. Janoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar G. Janoria more than expected).
Fields of papers citing papers by Kumar G. Janoria
This network shows the impact of papers produced by Kumar G. Janoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar G. Janoria. The network helps show where Kumar G. Janoria may publish in the future.
Co-authorship network of co-authors of Kumar G. Janoria
This figure shows the co-authorship network connecting the top 25 collaborators of Kumar G. Janoria. A scholar is included among the top collaborators of Kumar G. Janoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar G. Janoria. Kumar G. Janoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia breakdown → | 252 |
| 3 | 9 | |
| 4 | 37 | |
| 5 | 47 | |
| 6 | 16 | |
| 7 | 43 | |
| 8 | 162 | |
| 9 | 21 | |
| 10 | 13 | |
| 11 | 95 | |
| 12 | 57 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.